If we can identify when Alzheimer’s pathology starts, the efficacy of new drugs or other interventions to slow or prevent Alzheimer’s disease can be tested and monitored when the disease starts, instead of after it’s developed for 20 or 30 years and becomes clinically apparent.
By Alzheimer's Reading Room
This research caught my attention because I always felt that my mother's Alzheimer's disease was held partly in check because we did things that helped her develop new brain cells even at her advanced age. I am referring specifically to new brain cells in her hippocampus.
I often wondered, what if we knew my mother was going to develop Alzheimer's 20 years before her diagnosis?
Would the establishment of a set routine have slowed down the development of Alzheimer's?
Imagine if we had a way to push back the onset of Alzheimer's by five years. What would the result be? Statistical studies show that if we were to accomplish this the number of persons living with Alzheimer's would be cut in half.
|Subscribe to the Alzheimer's Reading Room|
Rudy Tanzi hypothesized,
"what we need is the equivalent of a statin for the brain.”
“It means you don’t want to hit A-beta with a sledgehammer,” Dr. Tanzi said. “It says what we need is the equivalent of a statin for the brain so you can dial it down but not turn it off.”Imagine if there was a pill available similar to statins for cholesterol, or blood pressure medications.
This would "dial back" the progression of Alzheimer's and delay the onset of the more debilitative stages of Alzheimer's.
This what we need, and we need it now. The research summary presented below shows us how we could move in this direction.
Cell Density Remains Constant as Brain Shrinks with Age
New, ultra-high-field magnetic resonance images (MRI) of the brain by researchers at the University of Illinois at Chicago provide the most detailed images to date to show that while the brain shrinks with age, brain cell density remains constant.
The study, of cognitively normal young and old adults, was published in the journal NMR in Biomedicine.
- The images provide the first evidence that in normal aging, cell density is preserved throughout the brain, not just in specific regions, as previous studies on human brain tissue have shown.
- The findings also suggest that the maintenance of brain cell density may protect against cognitive impairment as the brain gradually shrinks in normal aging.
The images were made at UIC by a powerful 9.4-Tesla MRI, the first of its kind for human imaging. The 9.4 T magnetic field is more than three times stronger than that of a typical MRI machine in a doctor’s office and is currently approved only for research. The strongest MRI units approved for clinical use are 3 T.
“The information provided by these 9.4-Tesla scans may be very useful in helping us to detect tiny losses of brain cells and the reduction in cell density that characterizes the early stages of neurodegenerative diseases that can take decades to develop before symptoms appear, like Alzheimer’s disease,” said Dr. Keith Thulborn, director of MRI research in the UIC College of Medicine and lead author of the report.
“If we can identify when Alzheimer’s pathology starts, the efficacy of new drugs or other interventions to slow or prevent Alzheimer’s disease can be tested and monitored when the disease starts, instead of after it’s developed for 20 or 30 years and becomes clinically apparent,” said Thulborn, who is professor of radiology, physiology and biophysics.Neuroscientists have long known that the brain shrinks with age, but for a long time they thought the loss in volume was associated with a loss of brain cells. That was disproven by studies that showed it is the neurons themselves that shrink while the number of cells remains the same in normal older adults.
Thulborn and his colleagues scanned the brains of 49 cognitively normal adults ranging in age from 21 to 80. All had at least a college education and were employed or, if retired, were active in their communities. All were without major medical, neurological or psychiatric disease and scored within the normal range for mental status.
The 9.4 Tesla MRI measures sodium ions, which are less concentrated by several orders of magnitude than the fat and water molecules detected with standard MRI. Sodium ions are present throughout the body and are pumped in and out of neurons to generate the electric potentials needed to spark nerve impulses. Sodium concentrations in the brain reflect neuron density. Areas of low sodium concentration indicate lots of neurons packed tightly together, while higher sodium concentration can indicate more space between cells — or the loss of cells, as in the case of neurodegenerative diseases.
Thulborn thinks the ultra-high-field scanners eventually will be approved for clinical use.
“We can use the 9.4 T to look at brain cell loss in real time in patients experiencing stroke, or to see whether chemotherapy for brain tumors is working in higher resolution that is just not available using the current 3 T clinical scanners,” he said.
This research was funded by National Institutes of Health grant RO1 CA129553.
Alzheimer's Disease Changing Patterns of Behavior
Creating Positive Patterns of Behavior in Alzheimer's Patients the Music CD
What is a Mediterranean Diet?
You are reading original content the Alzheimer's Reading Room